Related Experiment Video
Updated: Apr 22, 2026
10:09
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
9.0K
Beta cell connectivity in pancreatic islets: a type 2 diabetes target?
Guy A Rutter1, David J Hodson2
1Section of Cell Biology, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK. g.rutter@imperial.ac.uk.
Cellular and Molecular Life Sciences : CMLS
|October 18, 2014
Summary
Beta cell connectivity enhances insulin secretion through intercellular signaling within pancreatic islets. Disruptions in this communication may contribute to type 2 diabetes mellitus, suggesting potential therapeutic targets.
Area of Science:
- Endocrinology
- Cell Biology
- Diabetes Research
Background:
- Beta cell connectivity, or intercellular communication within pancreatic islets, is crucial for regulating insulin secretion.
- This phenomenon provides a 3D platform for signaling, organizing hormone release in response to glucose and other stimuli.
- Its importance in islet biology has been increasingly recognized.
Purpose of the Study:
- To review the mechanisms underlying beta cell connectivity.
- To discuss how these mechanisms may be impaired in type 2 diabetes mellitus (T2DM).
- To examine strategies for restoring insulin secretion by enhancing cell communication.
Main Methods:
- Literature review of studies on beta cell connectivity and T2DM.
- Analysis of intercellular signaling pathways in pancreatic islets.
- Exploration of therapeutic approaches targeting cell-cell communication.
Main Results:
- Beta cell connectivity facilitates coordinated insulin release and influences cellular responses.
- Environmental and genetic factors in T2DM can disrupt normal beta cell communication.
- Impaired connectivity contributes to dysregulated insulin secretion in T2DM.
Conclusions:
- Beta cell connectivity is a fundamental aspect of islet function.
- Targeting cell-cell communication pathways offers a potential therapeutic strategy for T2DM.
- Restoring or enhancing beta cell connectivity may improve insulin secretion and glycemic control.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
8
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
8
01:24Type II Diabetes II: Pathophysiology
6
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
01:26Type II Diabetes I: Introduction
5
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
5
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.7K
01:12Type I Diabetes I: Introduction
8
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
8
01:22Diabetes Mellitus: Overview and Type I Subtype
5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K